BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 27580691)

  • 1. Fatal 1918 pneumonia case complicated by erythrocyte sickling.
    Sheng ZM; Chertow DS; Morens DM; Taubenberger JK
    Emerg Infect Dis; 2010 Dec; 16(12):2000-1. PubMed ID: 21122243
    [No Abstract]   [Full Text] [Related]  

  • 2. Rare Cause of Acute Loss of Vision in a Patient With Sickle Cell Trait.
    Bojja S; Javed N; Allena N; Bojja S; Khaja M
    Cureus; 2023 Jul; 15(7):e42535. PubMed ID: 37637596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-Organ Morphological Findings in a Humanized Murine Model of Sickle Cell Trait.
    Trucas M; Burattini S; Porcu S; Simbula M; Ristaldi MS; Kowalik MA; Serra MP; Gobbi P; Battistelli M; Perra A; Quartu M
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central Retinal Artery Occlusion in a Young Patient With a Hidden Unusual Sickle Cell Trait.
    Semidey VA; Magliyah MS; Alali N; Hashem F; ALBalawi HB
    Cureus; 2023 Feb; 15(2):e34865. PubMed ID: 36923174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-center experience of LVAD implantation in patients with sickle-cell trait: A retrospective analysis.
    Khamees KA; Grasso E; Ibrahim A; Abdallah H; Adbelhamed MI; Sayin O; Lorusso R
    J Card Surg; 2022 Dec; 37(12):4816-4824. PubMed ID: 36413694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hematological and molecular analyses of the HbS allele among the Sudanese population.
    Khalafallah TO; Ajab Eldoor AA; Babker AM; Bin Shaya AS; Alfahed A; Alharithi NS; Aloraini GS; Waggiallah HA
    J Int Med Res; 2022 Sep; 50(9):3000605221125050. PubMed ID: 36134571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes of COVID-19 in patients with sickle cell disease and sickle cell trait: A critical appraisal of the literature.
    Hoogenboom WS; Alamuri TT; McMahon DM; Balanchivadze N; Dabak V; Mitchell WB; Morrone KB; Manwani D; Duong TQ
    Blood Rev; 2022 May; 53():100911. PubMed ID: 34838342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health services use by children identified as heterozygous hemoglobinopathy mutation carriers via newborn screening.
    Khangura SD; Potter BK; Davies C; Ducharme R; Bota AB; Hawken S; Wilson K; Karaceper MD; Klaassen RJ; Little J; Simpson E; Chakraborty P
    BMC Pediatr; 2021 Jul; 21(1):296. PubMed ID: 34210267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying Genetic and Biological Determinants of Race-Ethnic Disparities in Stroke in the United States.
    Kamin Mukaz D; Zakai NA; Cruz-Flores S; McCullough LD; Cushman M
    Stroke; 2020 Nov; 51(11):3417-3424. PubMed ID: 33104469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Splenic Infarct Secondary to High Altitude Exposure in Sickle Cell Trait Patients: A Case Series.
    Gonzalez L; Shapiro AF; Tafur A; Plaza-Meneses C; Sabando B
    Cureus; 2020 Aug; 12(8):e9815. PubMed ID: 32821639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kidney Function Decline among Black Patients with Sickle Cell Trait and Sickle Cell Disease: An Observational Cohort Study.
    Olaniran KO; Allegretti AS; Zhao SH; Achebe MM; Eneanya ND; Thadhani RI; Nigwekar SU; Kalim S
    J Am Soc Nephrol; 2020 Feb; 31(2):393-404. PubMed ID: 31810990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The indirect health effects of malaria estimated from health advantages of the sickle cell trait.
    Uyoga S; Macharia AW; Ndila CM; Nyutu G; Shebe M; Awuondo KO; Mturi N; Peshu N; Tsofa B; Scott JAG; Maitland K; Williams TN
    Nat Commun; 2019 Feb; 10(1):856. PubMed ID: 30787300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Red blood cell components: time to revisit the sources of variability.
    Sparrow RL
    Blood Transfus; 2017 Mar; 15(2):116-125. PubMed ID: 28263168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How benign is sickle cell trait?
    Gibson JS; Rees DC
    EBioMedicine; 2016 Sep; 11():21-22. PubMed ID: 27580691
    [No Abstract]   [Full Text] [Related]  

  • 15. Singer K, Fisher B. Studies on abnormal hemoglobins, VI: electrophoretic demonstration of type S (sickle cell) hemoglobin in erythrocytes incapable of showing the sickle cell phenomenon. Blood. 1953;8(3):270-275.
    Blood; 2016 Feb; 127(7):791. PubMed ID: 26893392
    [No Abstract]   [Full Text] [Related]  

  • 16. Sickle cell trait and renal papillary necrosis.
    Li EJ; Carroll VG
    Clin Pediatr (Phila); 2014 Sep; 53(10):1013-5. PubMed ID: 24807983
    [No Abstract]   [Full Text] [Related]  

  • 17. [Autosomal dominant polycystic kidney disease and sickle cell trait].
    Peces R; Peces C
    Nefrologia; 2011; 31(2):134-6. PubMed ID: 21461004
    [No Abstract]   [Full Text] [Related]  

  • 18. The carrier state for sickle cell disease is not completely harmless.
    Xu JZ; Thein SL
    Haematologica; 2019 Jun; 104(6):1106-1111. PubMed ID: 31097635
    [No Abstract]   [Full Text] [Related]  

  • 19. Metabolic Reprogramming in Sickle Cell Diseases: Pathophysiology and Drug Discovery Opportunities.
    Alramadhani D; Aljahdali AS; Abdulmalik O; Pierce BD; Safo MK
    Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806451
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.